Literature DB >> 17570932

Podocytes in HIV-associated nephropathy.

Ting-Chi Lu1, John Cijiang He, Paul E Klotman.   

Abstract

HIV-associated nephropathy (HIVAN) is the leading cause of end-stage renal failure in HIV-1 seropositive patients. The pathologic findings include collapsing focal segmental glomerulosclerosis with proliferation of epithelial cells in Bowman's space. Anatomically, these cells correspond to podocytes and exhibit a unique phenotype with loss of many differentiation markers including synaptopodin and dysregulation of the cell cycle markers consistent with proliferation. Podocyte dysfunction appears to be a direct result of HIV-1 protein expression, specifically Nef and Vpr as well as specific host factors that have yet to be elucidated. The mechanism by which Nef induces podocyte proliferation and dedifferentiation has been traced to its ability to activate several signaling pathways including Src-Stat3 and ras-raf-MAPK1, 2. Activation of the cAMP/PKA pathway with all-trans-retinoic acid appears to modulate these changes and returns podocytes to a differentiated, nonproliferating phenotype. Copyright 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17570932     DOI: 10.1159/000101800

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  18 in total

1.  Estimating podocyte number and density using a single histologic section.

Authors:  Madhusudan Venkatareddy; Su Wang; Yan Yang; Sanjeevkumar Patel; Larysa Wickman; Ryuzoh Nishizono; Mahboob Chowdhury; Jeffrey Hodgin; Paul A Wiggins; Roger C Wiggins
Journal:  J Am Soc Nephrol       Date:  2013-12-19       Impact factor: 10.121

2.  Hedgehog pathway plays a vital role in HIV-induced epithelial-mesenchymal transition of podocyte.

Authors:  Xiqian Lan; Hongxiu Wen; Kang Cheng; Andrei Plagov; Seyedeh Shadafarin Marashi Shoshtari; Ashwani Malhotra; Pravin C Singhal
Journal:  Exp Cell Res       Date:  2017-01-31       Impact factor: 3.905

3.  Epithelial-to-mesenchymal transition in podocytes mediated by activation of NADPH oxidase in hyperhomocysteinemia.

Authors:  Chun Zhang; Min Xia; Krishna M Boini; Cai-Xia Li; Justine M Abais; Xiao-Xue Li; Laura A Laperle; Pin-Lan Li
Journal:  Pflugers Arch       Date:  2011-06-07       Impact factor: 3.657

Review 4.  The glomerulus--a view from the outside--the podocyte.

Authors:  Huifang Cheng; Raymond C Harris
Journal:  Int J Biochem Cell Biol       Date:  2010-06-11       Impact factor: 5.085

5.  HIV therapy, metabolic and cardiovascular health are associated with glomerular hyperfiltration among men with and without HIV infection.

Authors:  Derek K Ng; Lisa P Jacobson; Todd T Brown; Frank J Palella; Jeremy J Martinson; Robert Bolan; Edgar R Miller; George J Schwartz; Alison G Abraham; Michelle M Estrella
Journal:  AIDS       Date:  2014-01-28       Impact factor: 4.177

Review 6.  Signaling in regulation of podocyte phenotypes.

Authors:  Peter Y Chuang; John C He
Journal:  Nephron Physiol       Date:  2009-01-13

Review 7.  Minimal change nephropathy and focal segmental glomerulosclerosis.

Authors:  Peter W Mathieson
Journal:  Semin Immunopathol       Date:  2007-10-23       Impact factor: 9.623

8.  Incorporation of podoplanin into HIV released from HEK-293T cells, but not PBMC, is required for efficient binding to the attachment factor CLEC-2.

Authors:  Chawaree Chaipan; Imke Steffen; Theodros Solomon Tsegaye; Stephanie Bertram; Ilona Glowacka; Yukinari Kato; Jan Schmökel; Jan Münch; Graham Simmons; Rita Gerardy-Schahn; Stefan Pöhlmann
Journal:  Retrovirology       Date:  2010-05-19       Impact factor: 4.602

Review 9.  Taking a hard look at the pathogenesis of childhood HIV-associated nephropathy.

Authors:  Patricio E Ray
Journal:  Pediatr Nephrol       Date:  2009-03-14       Impact factor: 3.714

10.  Nef and cell signaling transduction: a possible involvement in the pathogenesis of human immunodeficiency virus-associated dementia.

Authors:  Valeria Bergonzini; Arianna Calistri; Cristiano Salata; Claudia Del Vecchio; Elena Sartori; Cristina Parolin; Giogio Palù
Journal:  J Neurovirol       Date:  2009-05       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.